Accumulation of cyclic adenosine monophosphate in incubated slices of brain tissue. 2. Effects of depolarizing agents, membrane stabilizers, phosphodiesterase inhibitors, and adenosine analogs.
D000241:Adenosine / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000378:metabolism*; D002247:Carbon Isotopes; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D004347:Drug Interactions; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D066298:In Vitro Techniques; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology*; D010042:Ouabain / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D010744:Phosphoric Monoester Hydrolases / Q000037:antagonists & inhibitors*; D014118:Toxins, Biological / Q000494:pharmacology*; D014702:Veratrine / Q000494:pharmacology
D002247:Carbon Isotopes; D000697:Central Nervous System Stimulants; D009467:Neuromuscular Depolarizing Agents; D010726:Phosphodiesterase Inhibitors; D014118:Toxins, Biological; D010042:Ouabain; D006632:Histamine; D000242:Cyclic AMP; D010744:Phosphoric Monoester Hydrolases; D014702:Veratrine; D000241:Adenosine